Literature DB >> 18193361

The NKG2D receptor: immunobiology and clinical implications.

Steven J Burgess1, Kerima Maasho, Madhan Masilamani, Sriram Narayanan, Francisco Borrego, John E Coligan.   

Abstract

NK cells are critical components of our immune system functioning, in part, to recognize and then eradicate virally infected or tumorigenic cells without previous sensitization. One of the best-characterized activating receptors expressed on NK cells is the NKG2D receptor, which is capable of transmitting co-stimulatory signals by subsets of T cells. Viruses and tumors have evolved strategies to evade NKG2D-mediated immune recognition thus highlighting the importance of this receptor in immunity. This review will focus on the structure of NKG2D and its interaction with its diverse array of ligands, as well as highlighting current knowledge regarding NKG2D signal transduction and biological mechanisms that govern its cell surface expression. The impact that NKG2D has in disease pathologies is also assessed.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18193361     DOI: 10.1007/s12026-007-0060-9

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  112 in total

1.  Therapy-induced antibodies to MHC class I chain-related protein A antagonize immune suppression and stimulate antitumor cytotoxicity.

Authors:  Masahisa Jinushi; F Stephen Hodi; Glenn Dranoff
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-05       Impact factor: 11.205

2.  Nucleotide sequence of the human MHC class I MICA gene.

Authors:  S Bahram; N Mizuki; H Inoko; T Spies
Journal:  Immunogenetics       Date:  1996       Impact factor: 2.846

3.  Molecular cloning and characterization of pig immunoreceptor DAP10 and NKG2D.

Authors:  D Yim; H B Jie; J Sotiriadis; Y S Kim; K S Kim; M F Rothschild; L L Lanier; Y B Kim
Journal:  Immunogenetics       Date:  2001-04       Impact factor: 2.846

4.  Polymorphism of transmembrane region of MICA gene and Kawasaki disease.

Authors:  Y Huang; Y J Lee; M R Chen; C H Hsu; S P Lin; T C Sung; S C Chang; J G Chang
Journal:  Exp Clin Immunogenet       Date:  2000

5.  A direct role for NKG2D/MICA interaction in villous atrophy during celiac disease.

Authors:  Sophie Hüe; Jean-Jacques Mention; Renato C Monteiro; ShaoLing Zhang; Christophe Cellier; Jacques Schmitz; Virginie Verkarre; Nassima Fodil; Seiamak Bahram; Nadine Cerf-Bensussan; Sophie Caillat-Zucman
Journal:  Immunity       Date:  2004-09       Impact factor: 31.745

6.  IL-2-activated CD8+CD44high cells express both adaptive and innate immune system receptors and demonstrate specificity for syngeneic tumor cells.

Authors:  Salim Dhanji; Hung-Sia Teh
Journal:  J Immunol       Date:  2003-10-01       Impact factor: 5.422

7.  Human CD94 gene expression: dual promoters differing in responsiveness to IL-2 or IL-15.

Authors:  Louis D Lieto; Francisco Borrego; Chi-Hyun You; John E Coligan
Journal:  J Immunol       Date:  2003-11-15       Impact factor: 5.422

8.  NKG2D blockade prevents autoimmune diabetes in NOD mice.

Authors:  Kouetsu Ogasawara; Jessica A Hamerman; Lauren R Ehrlich; Helene Bour-Jordan; Pere Santamaria; Jeffrey A Bluestone; Lewis L Lanier
Journal:  Immunity       Date:  2004-06       Impact factor: 31.745

Review 9.  Vav proteins, masters of the world of cytoskeleton organization.

Authors:  Idit Hornstein; Andres Alcover; Shulamit Katzav
Journal:  Cell Signal       Date:  2004-01       Impact factor: 4.315

10.  Comparative analysis of human NK cell activation induced by NKG2D and natural cytotoxicity receptors.

Authors:  Pascale André; Roberta Castriconi; Marion Espéli; Nicolas Anfossi; Tiffany Juarez; Sophie Hue; Holli Conway; François Romagné; Alessandra Dondero; Marina Nanni; Sophie Caillat-Zucman; David H Raulet; Cristina Bottino; Eric Vivier; Alessandro Moretta; Pascale Paul
Journal:  Eur J Immunol       Date:  2004-04       Impact factor: 5.532

View more
  42 in total

1.  NKG2D initiates caspase-mediated CD3zeta degradation and lymphocyte receptor impairments associated with human cancer and autoimmune disease.

Authors:  Nobuyoshi Hanaoka; Bana Jabri; Zhenpeng Dai; Cezary Ciszewski; Anne M Stevens; Cassian Yee; Hideki Nakakuma; Thomas Spies; Veronika Groh
Journal:  J Immunol       Date:  2010-10-06       Impact factor: 5.422

2.  NKG2D receptor regulates human effector T-cell cytokine production.

Authors:  Amorette Barber; Charles L Sentman
Journal:  Blood       Date:  2011-04-25       Impact factor: 22.113

3.  EphA2 targeting peptide tethered bioreducible poly(cystamine bisacrylamide-diamino hexane) for the delivery of therapeutic pCMV-RAE-1γ to pancreatic islets.

Authors:  Katherine S Blevins; Ji Hoon Jeong; Mei Ou; Jonathan H Brumbach; Sung Wan Kim
Journal:  J Control Release       Date:  2011-10-28       Impact factor: 9.776

4.  Immobilized MHC class I chain-related protein A synergizes with IL-15 and soluble 4-1BB ligand to expand NK cells with high cytotoxicity ex vivo.

Authors:  Weijuan Gong; Weiming Xiao; Li Qian; Chunxiang Gong; Maozhi Hu; Xianyuan Pan; Mingchun Ji
Journal:  Cell Mol Immunol       Date:  2010-09-27       Impact factor: 11.530

5.  Cytokine alteration and speculated immunological pathophysiology in silicosis and asbestos-related diseases.

Authors:  Shuko Murakami; Yasumitsu Nishimura; Megumi Maeda; Naoko Kumagai; Hiroaki Hayashi; Ying Chen; Masayasu Kusaka; Takumi Kishimoto; Takemi Otsuki
Journal:  Environ Health Prev Med       Date:  2009-03-18       Impact factor: 3.674

6.  Generation, affinity maturation, and characterization of a human anti-human NKG2D monoclonal antibody with dual antagonistic and agonistic activity.

Authors:  Ka Yin Kwong; Sivasubramanian Baskar; Hua Zhang; Crystal L Mackall; Christoph Rader
Journal:  J Mol Biol       Date:  2008-09-16       Impact factor: 5.469

7.  HMBOX1 negatively regulates NK cell functions by suppressing the NKG2D/DAP10 signaling pathway.

Authors:  Longyan Wu; Cai Zhang; Jian Zhang
Journal:  Cell Mol Immunol       Date:  2011-06-27       Impact factor: 11.530

8.  Complex regulation of human NKG2D-DAP10 cell surface expression: opposing roles of the γc cytokines and TGF-β1.

Authors:  Yuk Pheel Park; Seung-Chul Choi; Patricia Kiesler; Aleksandra Gil-Krzewska; Francisco Borrego; Jennifer Weck; Konrad Krzewski; John E Coligan
Journal:  Blood       Date:  2011-08-03       Impact factor: 22.113

Review 9.  Natural killer cell receptors and their ligands in liver diseases.

Authors:  Satoshi Yamagiwa; Hiroteru Kamimura; Takafumi Ichida
Journal:  Med Mol Morphol       Date:  2009-03-18       Impact factor: 2.309

Review 10.  Immunogenetics of the NKG2D ligand gene family.

Authors:  Masanori Kasahara; Shigeru Yoshida
Journal:  Immunogenetics       Date:  2012-07-29       Impact factor: 2.846

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.